Lineage Cell Therapeutics Provides End of Year Shareholder Letter
The Pharma Data
DECEMBER 27, 2020
Following changes to our leadership team in late 2018 and early 2019, we have sought to transform Lineage into the preeminent allogeneic cell transplant company. Finally, we seek to generate compelling clinical data to support moving into late-stage clinical trials and eventual marketing authorizations.
Let's personalize your content